Piomic, part of Serpentine Ventures, saw its technology reconfirmed as highly effective in a recent study, showcasing significant wound reduction and ease of use. New potential applications include autolytic debridement and pressure ulcers.
Piomic, part of Serpentine Ventures, saw its technology reconfirmed as highly effective in a recent study, showcasing significant wound reduction and ease of use. New potential applications include autolytic debridement and pressure ulcers.
